Aviva’s Abbott ABT Stock Holding History

Aviva’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139M	Sell	1,528,922 -768,330	-33%	-$70.1M	0.2%	90
2026 Q1	$236M	Buy	2,297,252 +15,153	+0.7%	+$1.71M	0.4%	41
2025 Q4	$286M	Buy	2,282,099 +36,075	+2%	+$4.6M	0.48%	30
2025 Q3	$301M	Buy	2,246,024 +461,093	+26%	+$60.5M	0.55%	26
2025 Q2	$243M	Buy	1,784,931 +360,855	+25%	+$47.6M	0.5%	29
2025 Q1	$189M	Buy	1,424,076 +161,745	+13%	+$20.6M	0.46%	36
2024 Q4	$143M	Buy	1,262,331 +49,298	+4%	+$5.7M	0.37%	44
2024 Q3	$138M	Buy	1,213,033 +41,607	+4%	+$4.56M	0.36%	48
2024 Q2	$122M	Buy	1,171,426 +155,319	+15%	+$16.5M	0.34%	52
2024 Q1	$115M	Buy	1,016,107 +38,244	+4%	+$4.38M	0.38%	44
2023 Q4	$108M	Buy	977,863 +47,591	+5%	+$4.76M	0.39%	45
2023 Q3	$90.1M	Buy	930,272 +179,041	+24%	+$18.8M	0.38%	45
2023 Q2	$81.9M	Buy	751,231 +413,453	+122%	+$44.1M	0.33%	54
2023 Q1	$34.2M	Sell	337,778 -104,972	-24%	-$11.1M	0.15%	169
2022 Q4	$48.6M	Buy	442,750 +50,137	+13%	+$5.19M	0.24%	84
2022 Q3	$38M	Sell	392,613 -32,543	-8%	-$3.47M	0.22%	89
2022 Q2	$46.2M	Sell	425,156 -79,064	-16%	-$8.98M	0.25%	77
2022 Q1	$59.7M	Sell	504,220 -273,703	-35%	-$33.9M	0.3%	61
2021 Q4	$109M	Sell	777,923 -63,784	-8%	-$8.16M	0.46%	43
2021 Q3	$99.4M	Sell	841,707 -79,293	-9%	-$9.74M	0.44%	44
2021 Q2	$107M	Sell	921,000 -3,214	-0.3%	-$375K	0.47%	41
2021 Q1	$111M	Buy	924,214 +343,210	+59%	+$40.7M	0.54%	35
2020 Q4	$63.6M	Buy	581,004 +18,319	+3%	+$1.99M	0.33%	70
2020 Q3	$61.2M	Sell	562,685 -67,633	-11%	-$6.86M	0.36%	65
2020 Q2	$57.6M	Sell	630,318 -23,064	-4%	-$2.08M	0.36%	63
2020 Q1	$51.6M	Sell	653,382 -302,410	-32%	-$25.2M	0.38%	62
2019 Q4	$83M	Sell	955,792 -140,663	-13%	-$11.8M	0.5%	46
2019 Q3	$91.7M	Sell	1,096,455 -16,853	-2%	-$1.43M	0.62%	36
2019 Q2	$93.6M	Sell	1,113,308 -118,347	-10%	-$9.32M	0.64%	34
2019 Q1	$98.5M	Buy	1,231,655 +1,865	+0.2%	+$139K	0.66%	33
2018 Q4	$89M	Sell	1,229,790 -17,571	-1%	-$1.23M	0.66%	30
2018 Q3	$91.5M	Buy	1,247,361 +39,665	+3%	+$2.6M	0.5%	43
2018 Q2	$73.7M	Buy	1,207,696 +346,717	+40%	+$21M	0.43%	52
2018 Q1	$51.6M	Sell	860,979 -80,476	-9%	-$4.85M	0.32%	84
2017 Q4	$53.7M	Sell	941,455 -137,886	-13%	-$7.64M	0.3%	80
2017 Q3	$57.6M	Buy	1,079,341 +9,510	+0.9%	+$477K	0.31%	77
2017 Q2	$52M	Buy	1,069,831 +2,210	+0.2%	+$100K	0.29%	79
2017 Q1	$47.4M	Buy	1,067,621 +101,859	+11%	+$4.4M	0.27%	88
2016 Q4	$37.1M	Buy	965,762 +58,658	+6%	+$2.33M	0.22%	104
2016 Q3	$38.4M	Sell	907,104 -74,731	-8%	-$3.2M	0.24%	97
2016 Q2	$38.6M	Buy	981,835 +130,897	+15%	+$5.21M	0.26%	88
2016 Q1	$35.6M	Buy	850,938 +10,904	+1%	+$432K	0.26%	81
2015 Q4	$37.7M	Sell	840,034 -4,571	-0.5%	-$202K	0.29%	80
2015 Q3	$34M	Sell	844,605 -63,725	-7%	-$3M	0.28%	84
2015 Q2	$44.6M	Sell	908,330 -26,843	-3%	-$1.29M	0.32%	73
2015 Q1	$43.3M	Buy	935,173 +102,734	+12%	+$4.72M	0.3%	76
2014 Q4	$37.5M	Sell	832,439 -15,590	-2%	-$679K	0.29%	82
2014 Q3	$35.3M	Sell	848,029 -17,100	-2%	-$723K	0.28%	82
2014 Q2	$35.4M	Buy	865,129 +5,245	+0.6%	+$206K	0.27%	87
2014 Q1	$33.1M	Buy	859,884 +55,524	+7%	+$2.14M	0.27%	90
2013 Q4	$30.8M	Sell	804,360 -18,453	-2%	-$680K	0.26%	98
2013 Q3	$27.3M	Buy	822,813 +174,821	+27%	+$6.13M	0.24%	103
2013 Q2	$22.6M	Buy	+647,992	New	+$23.8M	0.23%	113

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Aviva's ABT Position: Q2 2026 in Review

Aviva reduced its Abbott (ABT) stake by 33% in Q2 2026, selling an estimated $70.1M and leaving 1,528,922 shares worth $139M. The position accounts for 0.2% of the portfolio, ranked #90.

Aviva first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $301M in Q3 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Aviva held 1,528,922 shares of Abbott worth $139M as of Q2 2026.
Aviva sold 768,330 Abbott shares in Q2 2026, an estimated $70.1M.
Abbott made up 0.2% of Aviva's portfolio in Q2 2026, its #90 holding.
Aviva first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
Aviva's Abbott position peaked at $301M in Q3 2025.
2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.